Efficacy and safety of PD-1 and PD-L1 inhibitors combined with chemotherapy in randomized clinical trials among triple-negative breast cancer
Background: The combination of immune checkpoint inhibitors (ICIs) and chemotherapy (CT) is a new strategy to explore cancer treatment in recent years, and it is also practiced in triple-negative breast cancer (TNBC). However, several published randomized controlled trials (RCTs) reported heterogene...
Zapisane w:
Główni autorzy: | , , , , , , , , |
---|---|
Format: | Książka |
Wydane: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Hasła przedmiotowe: | |
Dostęp online: | Connect to this object online. |
Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|
Internet
Connect to this object online.3rd Floor Main Library
Sygnatura: |
A1234.567 |
---|---|
Egzemplarz 1 | Dostępne |